New Medicare rules for a small but promising class of cancer drugs may cause thousands of lymphoma patients to lose access to the treatment. The companies that make the drugs, and patient advocates, say the changes will cut reimbursement for the medicines and cause many hospitals to stop offering the treatments.
Trending:
Medicare cuts funds for cancer treatments